Dinawanao, Marjurie S.

HRN: 04-35-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2025
CEFTRIAXONE 1G (VIAL)
08/02/2025
08/09/2025
IV
3g
Od
Hansen’s Dse; Uti; G6pd
Checking Initial Appropriateness 
08/02/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/02/2025
08/09/2025
IV
300mg
Q6
Hansen’s Dse; Uti; G6pd
Checking Initial Appropriateness 
08/02/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/02/2025
08/09/2025
TOPICAL
1%
Bid
Hansens Disease
Checking Initial Appropriateness 
08/06/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/06/2025
08/13/2025
IV
1.6g
Q6hours
Sepsis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: